Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 2
2002 4
2003 3
2004 2
2005 3
2008 2
2009 4
2010 10
2011 8
2012 15
2013 13
2014 16
2015 16
2016 22
2017 5
2018 6
2019 3
2020 8
2021 5
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.
van Dijk N, Gil-Jimenez A, Silina K, Hendricksen K, Smit LA, de Feijter JM, van Montfoort ML, van Rooijen C, Peters D, Broeks A, van der Poel HG, Bruining A, Lubeck Y, Sikorska K, Boellaard TN, Kvistborg P, Vis DJ, Hooijberg E, Schumacher TN, van den Broek M, Wessels LFA, Blank CU, van Rhijn BW, van der Heijden MS. van Dijk N, et al. Among authors: van rhijn bw. Nat Med. 2020 Dec;26(12):1839-1844. doi: 10.1038/s41591-020-1085-z. Epub 2020 Oct 12. Nat Med. 2020. PMID: 33046870 Clinical Trial.
Landmarks in non-muscle-invasive bladder cancer.
Mertens LS, Neuzillet Y, Horenblas S, van Rhijn BW. Mertens LS, et al. Among authors: van rhijn bw. Nat Rev Urol. 2014 Aug;11(8):476-80. doi: 10.1038/nrurol.2014.130. Epub 2014 Jul 1. Nat Rev Urol. 2014. PMID: 24980189 Review.
Genetics and biological markers in urachal cancer.
Behrendt MA, van Rhijn BW. Behrendt MA, et al. Among authors: van rhijn bw. Transl Androl Urol. 2016 Oct;5(5):655-661. doi: 10.21037/tau.2016.04.01. Transl Androl Urol. 2016. PMID: 27785422 Free PMC article. Review.
Editorial comment.
van Rhijn BW. van Rhijn BW. J Urol. 2012 Feb;187(2):462. doi: 10.1016/j.juro.2011.10.172. Epub 2011 Dec 15. J Urol. 2012. PMID: 22177146 No abstract available.
The molecular background of urothelial cancer: ready for action?
van der Heijden MS, van Rhijn BW. van der Heijden MS, et al. Among authors: van rhijn bw. Eur Urol. 2015 Feb;67(2):202-3. doi: 10.1016/j.eururo.2014.07.017. Epub 2014 Aug 4. Eur Urol. 2015. PMID: 25103696 No abstract available.
Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network.
Zuiverloon TCM, van Kessel KEM, Bivalacqua TJ, Boormans JL, Ecke TH, Grivas PD, Kiltie AE, Liedberg F, Necchi A, van Rhijn BW, Roghmann F, Sanchez-Carbayo M, Schmitz-Dräger BJ, Wezel F, Kamat AM. Zuiverloon TCM, et al. Among authors: van rhijn bw. Urol Oncol. 2018 Sep;36(9):423-431. doi: 10.1016/j.urolonc.2018.01.014. Epub 2018 Mar 2. Urol Oncol. 2018. PMID: 29496372 Review.
Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines.
Schmitz-Dräger BJ, Kuckuck EC, Zuiverloon TC, Zwarthoff EC, Saltzman A, Srivastava A, Hudson MA, Seiler R, Todenhöfer T, Vlahou A, Grossman HB, Schoenberg MP, Sanchez-Carbayo M, Brünn LA, van Rhijn BW, Goebell PJ, Kamat AM, Roupret M, Shariat SF, Kiemeney LA. Schmitz-Dräger BJ, et al. Among authors: van rhijn bw. Urol Oncol. 2016 Oct;34(10):437-51. doi: 10.1016/j.urolonc.2016.05.030. Epub 2016 Sep 15. Urol Oncol. 2016. PMID: 27641313 Review.
117 results